Pardes Biosciences, Inc.
Pardes Biosciences, Inc. (PRDS) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
PRDS · net income · updated Jun 9, 2026
Core profitability metrics
PRDS · net income · margin · TTM · CAGRNet income was −$93.5M for FY2022 (fiscal year ending 2022-12-31), down 142.4% year-over-year. Net profit margin was —.
Annual net income history
▸ FMP /income-statement · Annual · PRDS net income history · PRDS profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Pardes Biosciences, Inc. (PRDS) reported net income of −$93.5M for FY2022 (fiscal year ending 2022-12-31), down 142.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Pardes Biosciences, Inc. has not yet achieved annual profitability based on available data (2 fiscal years). The company has reported net losses across all available periods.
Pardes Biosciences, Inc.'s net profit margin was — for FY2022, based on the latest annual results.
Investors sometimes search for "Pardes Biosciences, Inc. net worth" — the company's market capitalization is a separate figure from PRDS net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
PRDS net income · 4 questionsPardes Biosciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $93.5M for FY2022.
▸ Source: FMP /income-statement · GAAP · Pardes Biosciences, Inc. · Pardes Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026